CLIC Sargent, the leading charity for children and young people with cancer, has welcomed plans to trial a new therapy to treat leukaemia following the use of immune cell therapy on 16-month old Layla Richards.
Dara de Burca, Director of Services at CLIC Sargent, said: “It’s wonderful to hear that this revolutionary new therapy has been used to treat Layla.
“Any breakthrough that potentially increases survival rates of children diagnosed with cancer is to be warmly welcomed.
“We are particularly pleased to hear that the therapy will be trialled with more children with leukaemia from next year.
“Going through treatment for leukaemia, which can take up to three years, can be incredibly stressful, even when treatment is working, and it has a profound emotional, practical and financial impact on the child and the whole family.”
For more information contact Helen Thomas on 020 8752 2855 or email firstname.lastname@example.org. Outside office hours please call 08448 481189.
About childhood cancer
Every day, 10 children and young people in the UK hear the shocking news they have cancer. Treatment normally starts immediately, is often given many miles from home and can last for up to three years. Although survival rates are over 80%, cancer remains the single largest cause of death from disease in children and young people in the UK.
About CLIC Sargent
CLIC Sargent is the UK’s leading cancer charity for children and young people, and their families. We provide clinical, practical and emotional support to help them cope with cancer and get the most out of life. For more information visit www.clicsargent.org.uk
Note to sub editors
Please note that the name ‘CLIC Sargent’ should not be abbreviated to CLIC, and that the word ‘CLIC’ should always appear in capitals, as above.